16 January. 2021
Cancer project proposes to design a low-cost mobile VR system to complement patients’ physiotherapy and psychotherapy. The system will be able to accurately monitor the physical training performed by the patent on a daily basis. In addition, the system will assess in real-time the patient’s performance and will provide guidance to improve the training tasks accuracy.
The system will also serve as a virtual platform to facilitate remote psychotherapy for the cancer patients and their psychotherapists.
To do so, it leverages on a few state-of-the-art technologies:
(1) Virtual Reality, through the use of low-cost Head-Mounted Display (HMD) systems, which will surround the user’s vision completely. The VR-HMDs include head-tracking machinery to track the motion of the user’s head and present a 360° Virtual Environment;
and (2) Interactivity Devices, to enhance the user’s engagement into the Virtual Environment and to monitor and correct the user’s movement. These interactive devices will include Arduinos, which will facilitate more natural movements and navigations in the Virtual Environment.
- Bachelor or master’s degree in one of the following areas or a related area: computer science, graphic design, digital arts, cognitive systems.
- Programming skills in C++ or C#, and familiarity with game engines such as Unity3D and Unreal Engine. Experience with VR development.
- Ability to create 3D models to be used in VR applications. Proficiency in 3DS Max, Maya or other 3D modeling software and Photoshop. Knowledge and ability to implement the full game asset pipeline, with experience in Substance Design a plus.
- Bio-signals Analysis skills, preferably in Electrocardiography (ECG), Photoplethysmogram (PPG), Electromyography (EMG), Electrodermal Activity (EDA).
The successful candidate will be: (1) designing and developing Virtual Reality environments; (2) programming tracking devices (such as Arduinos), and or bio-signal devices (such as myo armband) suitable to the needs of a people with dementia and cancer patients; and (3) analysing bio-signals.